Apogee Enterprises

Yahoo Finance • 11 days ago

1 Industrials Stock with Exciting Potential and 2 We Find Risky

Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. They are also bound to benefit from a friendlier regulatory environment with the Trump administration, and this excite... Full story

Yahoo Finance • 2 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apogee Enterprises, Inc. - APOG

NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Apogee Enterprises, Inc. (“Apogee” or the “Company”) (NASDAQ: APOG). Such investors are advised to contact Danielle Peyton at new... Full story

Yahoo Finance • 3 months ago

NN, Redwire, Array, Apogee, and Winnebago Shares Plummet, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after major indices pulled back from record highs reached the previous week. The S&P 500 and Nasdaq were under pressure as the dominant artificial intelligence trade cooled o... Full story

Yahoo Finance • 4 months ago

Wall Street Sees a 62% Upside to Apogee Enterprises (APOG)

Apogee Enterprises, Inc. (NASDAQ:APOG) is one of the best dividend stocks to buy. As of December 5, the average price target for APOG suggests an upside of 27%, however, the Street high indicates an upside of 62%. Previously, on November... Full story

Yahoo Finance • 4 months ago

Cash-Producing Stock to Target This Week and 2 We Question

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. Luckily for you, we built StockStory t... Full story

Yahoo Finance • 5 months ago

A. O. Smith (AOS) Q3 Earnings Report Preview: What To Look For

Water heating and treatment solutions company A.O. Smith (NYSE:AOS) will be reporting results this Tuesday before the bell. Here’s what you need to know. A. O. Smith beat analysts’ revenue expectations by 1.2% last quarter, reporting reve... Full story

Yahoo Finance • 6 months ago

Apogee beats top-line and bottom-line estimates; updates FY26 outlook

* Apogee press release [https://seekingalpha.com/pr/20261704-apogee-enterprises-reports-fiscal-2026-second-quarter-results] (NASDAQ:APOG [https://seekingalpha.com/symbol/APOG]): Q2 Non-GAAP EPS of $0.98 beats by $0.14. * Revenue of $35... Full story

Yahoo Finance • 6 months ago

Apogee Enterprises Inc. Profit Retreats In Q2

(RTTNews) - Apogee Enterprises Inc. (APOG) announced earnings for second quarter that Drops, from last year The company's earnings totaled $23.65 million, or $1.10 per share. This compares with $30.57 million, or $1.40 per share, last ye... Full story

Yahoo Finance • 6 months ago

Stocks Fall on Higher Bond Yields and Weakness in Chipmakers

The S&P 500 Index ($SPX) (SPY) today is down -0.24%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.36%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.32%.  December E-mini S&P futures (ESZ25) are down -0.26%, and December E-... Full story

Yahoo Finance • 6 months ago

Stocks Pressured by Higher Bond Yields

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) today is down -0.07%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/futures... Full story

Yahoo Finance • 6 months ago

Here are the major earnings after the close Thursday

Major earnings expected after the bell on Thursday include: * Apogee Enterprises (APOG [https://seekingalpha.com/symbol/APOG]) * Applied Digital Corporation (APLD [https://seekingalpha.com/symbol/APLD]) * Levi Strauss & Co. (LEVI [h... Full story

Yahoo Finance • 6 months ago

Stocks Muted Before the Open With Focus on Earnings Season

December S&P 500 E-Mini futures (ESZ25 [https://www.barchart.com/futures/quotes/ESZ25]) are up +0.01%, and December Nasdaq 100 E-Mini futures (NQZ25 [https://www.barchart.com/futures/quotes/NQZ25/overview]) are down -0.03% this morning, st... Full story

Yahoo Finance • 6 months ago

Earnings week ahead: PEP, DAL, TLRY, STZ, MKC, and more

[Third Quarter Q3 Profits Stock Trading Chart 3D Background] filo The upcoming first full week of October marks the beginning of the Q3 earnings season, with several notable names across consumer and technology set to report. Investors w... Full story

Yahoo Finance • 6 months ago

3 out of 5 companies miss EPS estimates this week: Earnings Scorecard

[Data analytics dashboard display. Business and financial investment. HUD infographic of financial. Information reports of business strategy for investment. 3d rendering] KanawatTH/iStock via Getty Images Wall Street's major averages cl... Full story

Yahoo Finance • 7 months ago

InvestingPro Fair Value model captures 43% downside in Apogee Therapeutics

In March 2024, InvestingPro’s Fair Value model identified (NASDAQ:APGE) as significantly overvalued at $66.54, challenging the prevailing bullish sentiment. Today’s analysis validates that contrarian call, with the stock trading at $38.30,... Full story

Yahoo Finance • 8 months ago

Apogee Enterprises announces leadership changes in architectural segments

MINNEAPOLIS - Apogee Enterprises, Inc. (NASDAQ:APOG), a profitable company with a market capitalization of $891 million and currently trading below its InvestingPro Fair Value, announced Thursday the appointment of two new business segment... Full story

Yahoo Finance • 9 months ago

Regeneron stock price target raised to $584 from $560 at UBS on Eylea outlook

Investing.com - UBS raised its price target on Regeneron Pharmaceuticals (NASDAQ:REGN) to $584.00 from $560.00 while maintaining a Neutral rating on the stock. According to InvestingPro data, Regeneron currently trades at a P/E ratio of 13... Full story

Yahoo Finance • 9 months ago

Stifel reiterates Buy rating on Apogee Therapeutics stock amid positive AD data

Investing.com - Stifel has reiterated its Buy rating and $95.00 price target on Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE) following recent Phase 2a data for its atopic dermatitis (AD) treatment APG777. According to InvestingPro d... Full story

Yahoo Finance • 9 months ago

Bernstein reiterates Outperform rating on Regeneron stock at $750

Investing.com - Bernstein SocGen Group has reiterated an Outperform rating on Regeneron Pharmaceuticals (NASDAQ:REGN) with a price target of $750.00. The company, currently trading at a PEG ratio of 0.77, shows strong potential with a "GRE... Full story

Yahoo Finance • 9 months ago

Canaccord Genuity reaffirms Buy rating on Apogee Therapeutics stock after positive trial data

Investing.com - Canaccord Genuity has reiterated its Buy rating and $89.00 price target on Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE) following positive clinical trial results for its atopic dermatitis treatment. The target repres... Full story